D.C.’s New Crime Lab Goes Under the Microscope
By Editorial,
Washington Post Editorial
| 03. 11. 2015
WHAT’S THE point of spending millions of dollars on a crime lab if people don’t trust its findings and won’t use it? That is one question D.C. officials should be asking in light of the unsettling revelation that the U.S. Attorney’s Office has stopped sending DNA evidence to the new Consolidated Forensic Laboratory because it claims there have been serious mistakes. Far more than money is at issue: Forensics plays a key role in determining the guilt or innocence of crime suspects. The concerns of federal prosecutors must be investigated and the integrity of the lab assured.
In January federal prosecutors stopped sending evidence for DNA testing to the crime lab, which is operated by the District’s Department of Forensic Sciences, opting instead to pay for tests at outside labs. The move, as The Post’s Keith L. Alexander reported, came after an outside expert, in a routine review of evidence for an upcoming case, found errors in the interpretation of test results; a subsequent review of 116 cases by two nationally known experts found what federal prosecutors characterized as...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...